A citation-based method for searching scientific literature

Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
Times Cited: 63







List of co-cited articles
268 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.
Lorelei A Mucci, Jacob B Hjelmborg, Jennifer R Harris, Kamila Czene, David J Havelick, Thomas Scheike, Rebecca E Graff, Klaus Holst, Sören Möller, Robert H Unger,[...]. JAMA 2016
272
3

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Kathryn A Phillips, Patricia A Deverka, Gillian W Hooker, Michael P Douglas. Health Aff (Millwood) 2018
62
3


Improving Direct-to-Consumer Medical Testing.
Ann M Gronowski, Shannon Haymond, Stephen R Master. JAMA 2017
5
40

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
130
3

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
97
3

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
Holly LaDuca, Eric C Polley, Amal Yussuf, Lily Hoang, Stephanie Gutierrez, Steven N Hart, Siddhartha Yadav, Chunling Hu, Jie Na, David E Goldgar,[...]. Genet Med 2020
39
5


Implementing a Virtual Health Telemedicine Program in a Community Setting.
Scott M Weissman, Kate Zellmer, Nicole Gill, Deborah Wham. J Genet Couns 2018
16
12

Online genetic counseling from the providers' perspective: counselors' evaluations and a time and cost analysis.
Ellen Otten, Erwin Birnie, Adelita V Ranchor, Irene M van Langen. Eur J Hum Genet 2016
17
11

Current conditions in medical genetics practice.
Deborah R Maiese, Alisha Keehn, Megan Lyon, David Flannery, Michael Watson. Genet Med 2019
34
5

Clinical models of telehealth in genetics: A regional telegenetics landscape.
Alissa B Terry, Amanda Wylie, Melissa Raspa, Beth Vogel, Kunal Sanghavi, Luba Djurdjinovic, Michele Caggana, Joann Bodurtha. J Genet Couns 2019
15
13

"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.
Chrystelle Colas, Lisa Golmard, Antoine de Pauw, Sandrine M Caputo, Dominique Stoppa-Lyonnet. Breast 2019
12
16

The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
Niki M Medendorp, Pomme E A van Maarschalkerweerd, Laxsini Murugesu, Joost G Daams, Ellen M A Smets, Marij A Hillen. Patient Educ Couns 2020
4
50

Molecular genetic testing and the future of clinical genomics.
Sara Huston Katsanis, Nicholas Katsanis. Nat Rev Genet 2013
197
3

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
59
3

Physician interpretation of variants of uncertain significance.
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
23
8



Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, Claudine Isaacs, Chanita Hughes, Tiffani DeMarco, Clinton Finch, Caryn Lerman. J Clin Oncol 2003
94
1


Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.
C M Julian-Reynier, L J Bouchard, D G Evans, F A Eisinger, W D Foulkes, B Kerr, I R Blancquaert, J P Moatti, H H Sobol. Cancer 2001
71
1

Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.
Kathleen R Blazer, Deborah J Macdonald, Julie O Culver, Carin R Huizenga, Robert J Morgan, Gwen C Uman, Jeffrey N Weitzel. Genet Med 2011
26
3


The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
278
1



ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.
Colin C Pritchard, Christina Smith, Stephen J Salipante, Ming K Lee, Anne M Thornton, Alex S Nord, Cassandra Gulden, Sonia S Kupfer, Elizabeth M Swisher, Robin L Bennett,[...]. J Mol Diagn 2012
139
1


Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
1

Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives.
Audrey Ardern-Jones, Regina Kenen, Elly Lynch, Rebecca Doherty, Rosalind Eeles. Hered Cancer Clin Pract 2010
16
6

Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment.
D J MacDonald, J Choi, B Ferrell, S Sand, S McCaffrey, K R Blazer, M Grant, J N Weitzel. J Med Genet 2002
17
5

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
3

Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer.
Sandra van Dijk, Wilma Otten, Rob A E M Tollenaar, Christi J van Asperen, Aad Tibben. Genet Med 2008
13
7


Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity.
Elizabeth R Walsh, Prapaporn Pisitkun, Elisaveta Voynova, Jonathan A Deane, Bethany L Scott, Rachel R Caspi, Silvia Bolland. Proc Natl Acad Sci U S A 2012
61
1

Second primary breast cancer occurrence according to hormone receptor status.
Allison W Kurian, Laura A McClure, Esther M John, Pamela L Horn-Ross, James M Ford, Christina A Clarke. J Natl Cancer Inst 2009
79
1

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
1

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Anne Uyei, Susan K Peterson, Julie Erlichman, Kristine Broglio, Sandra Yekell, Kathkeen Schmeler, Karen Lu, Funda Meric-Bernstam, Chris Amos, Louise Strong,[...]. Cancer 2006
45
2

A systematic review and meta-analysis of family history and risk of ovarian cancer.
J F Stratton, P Pharoah, S K Smith, D Easton, B A Ponder. Br J Obstet Gynaecol 1998
138
1

Familial breast cancer: risk to the contralateral breast.
R E Harris, H T Lynch, H A Guirgis. J Natl Cancer Inst 1978
70
1



Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007.
Armando E Giuliano, Susan Boolbol, Amy Degnim, Henry Kuerer, A Marilyn Leitch, Monica Morrow. Ann Surg Oncol 2007
82
1

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.
Ashley Stuckey, Don Dizon, Jennifer Scalia Wilbur, Jessica Kent, Trevor Tejada-Berges, Jennifer Gass, Robert Legare. Gynecol Obstet Invest 2010
14
7

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
1

The emergence of an ethical duty to disclose genetic research results: international perspectives.
Bartha Maria Knoppers, Yann Joly, Jacques Simard, Francine Durocher. Eur J Hum Genet 2006
193
1

The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews.
Heather A Douglas, Rebekah J Hamilton, Robin E Grubs. J Genet Couns 2009
41
2

Communication of genetic information by other health professionals: the role of the genetic counsellor in specialist clinics.
Rosie O'Shea, Anne Marie Murphy, Eileen Treacy, Sally Ann Lynch, Kathryn Thirlaway, Debby Lambert. J Genet Couns 2011
7
14

Cancer genetics clinics and the surgeon: a valuable role for family history screening.
G L Williams, J Gray, J Beynon. Ann R Coll Surg Engl 2007
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.